|
Medical news
Message: This news feed will stop on Jan 23 2012. Thank you for your custom.
Fri, 27 Jan 2012 22:33:00 GMT
Sponsored Link
Material Report - HRT O&G and TNK-Brasil announce the filing at ANP for the transfer of 45% of the 21 blocks in the Solimões Basin
Fri, 27 Jan 2012 22:33:00 GMT
RIO DE JANEIRO, Jan. 27, 2012 /CNW/ - HRT Participações em Petróleo S.A. (the "Company" or "HRT") (BM&FBOVESPA: HRTP3, TSX-V: HRP), announces that its subsidiary HRT O&G Exploração e Produção de Petróleo Ltda. ("HRT O&G") filed a request with ANP
Material Report - HRT O&G and TNK-Brasil announce the filing at ANP for the transfer of 45% of the 21 blocks in the Solimões Basin
Fri, 27 Jan 2012 22:33:00 GMT
HRT Participacões em Petróleo S.A. (the "Company" or "HRT") (BM&FBOVESPA: HRTP3, TSX-V: HRP), announces that its subsidiary HRT O&G Exploracão e Producão de Petróleo Ltda. ("HRT O&G") filed a request with ANP for the transfer of 45% of the 21 blocks
FDA Approves Pfizer Kidney Cancer Drug Inlyta
Fri, 27 Jan 2012 22:33:00 GMT
Dow Jones Newswires Related Stocks DOW JONES NEWSWIRES U.S. regulators approved Pfizer Inc.'s (PFE) kidney cancer drug Inlyta Friday, the latest of several drugs to be approved for the disease in recent years. U.S. Food and Drug Administration on Friday
FDA Approves Amylin's Bydureon Diabetes Drug After Delays
Fri, 27 Jan 2012 22:32:00 GMT
The U.S. Food and Drug Administration approved Amylin Pharmaceuticals Inc.'s (AMLN) diabetes drug Bydureon following a prolonged regulatory process in which the agency required extra testing to alleviate safety concerns. The agency approved the drug to |
Popular Searches
|